Jimbiosis Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.25 M
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
About Jimbiosis Healthcare
Jimbiosis Healthcare Private Limited (JHPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 December 2010 and has a history of 14 years and two months. Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.25 M.
The company currently has active open charges totaling ₹1.00 M.
Rajesh Sah, Satyajit Acharjee, Pradip Ghosh, and One other member serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110WB2010PTC155445
- Company No.
155445
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Jimbiosis Healthcare?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Sah  | Director | 06-Dec-2010 | Current |
| Satyajit Acharjee | Director | 06-Dec-2010 | Current |
| Pradip Ghosh | Director | 06-Dec-2010 | Current |
| Tushar Ghosh | Director | 06-Dec-2010 | Current |
Financial Performance of Jimbiosis Healthcare.
Jimbiosis Healthcare Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jimbiosis Healthcare?
In 2017, Jimbiosis Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jibok Pharmaceuticals Private LimitedRajesh Sah, Satyajit Acharjee and 2 more are mutual person
- North Twenty Four Healthcare Limited
Rajesh Sah is a mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2022 | Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Jimbiosis Healthcare?
Unlock and access historical data on people associated with Jimbiosis Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jimbiosis Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jimbiosis Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
